Print Email

Practice Resources  |  Antiemetics Study Group

MASCC Antiemetic Guidelines
©MASCC, Multinational Association for Supportive Care in Cancer™ •  All rights reserved worldwide. 

icon  MASCC/ESMO Antiemetic Guidelines

Organizing and Overall Meeting Chairs:  Matti Aapro, MD, Richard J. Gralla, MD, Jørn Herrstedt, MD, DMSci, Alex Molassiotis, RN, PhD, Fausto Roila, MD for the ESMO/MASCC Guidelines Working Group.

alt Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. 
Ann Oncol. 2010;21(suppl 5):v232-43.

Antiemetic Publications

Antiemetic Guidelines 2010 of the MASCC Antiemetic Study Group. Courtesy of MASCC and Springer.
Udated full text version of the
MASCC/ESMO Antiemetic Guideline papers found in Supportive Care in Cancer, vol. 19, Supplement 1/March 2011.
The papers in this supplemental issue of Supportive Care in Cancer represent a detailed summary of the deliberations from the consensus guideline meeting that took place in Perugia, Italy, in June 2009. Please refer to the PowerPoint guideline presentation for the most recent and updated version of the MASCC/ESMO Antiemetic Guideline.

download  Download the Guidelines

English - Version 1.1 - Updated March 2016   |   Guidelines-English    |   2016 Guidelines-English  (pptx)

icon Translations  -  Translation Policy   •  For more translation information please contact Anne Young at ayoung@mascc.org

Arabic - Translated June 2010MASCC Guidelines Arabic 
Translated by Bassam Estfan

Chinese - Translated  April 2011MASCC Guidelines Chinese    |   MASCC Guidelines Chinese  (ppt)
Translation provided by Shiyong Wang

French- Translated April 2012MASCC Guidelines French    |   MASCC Guidelines French  (ppt)

GermanTranslated  May 2016MASCC Guidelines German   |   MASCC Guidelines German  (pptx)
Translation provided by ASORS

Greek - Translated  November 2010MASCC Guidelines Greek    |   MASCC Guidelines Greek  (pps)
Translated by Ourania Nicolatou-Galitis and Erofili Papadopoulou

Japanese Translation - Translated May 2016 - MASCC Guidelines Japanese    |   MASCC Guidelines Japanese  (ppt)
Translated by Springer and reviewed by JASCC

Portuguese - Translated March 2011MASCC Guidelines Portuguese    |   MASCC Guidelines Portuguese  (ppt)

Russian - Translated  August 2011MASCC Guidelines Russian   |   MASCC Guidelines Russian  (ppt)
Translated by Anton Snegovoy

Serbian - Translated  April 2013MASCC Guidelines Serbian   |   MASCC Guidelines Serbian  (ppt)
Translated by Snezana Bosnjak, Jelena Dimitrijevic and Ana Vujovic

Spanish - Translated August 2011MASCC Guidelines Spanish   |   MASCC Guidelines Spanish  (ppt)
Translated by Alvaro Menendez

Turkish - Translated  August 2010 - MASCC_Guidelines-Turkish   |    MASCC Guidelines Turkish  (ppt)
Translated by Ahmet Sezer, Ali Ayberk Besen, Huseyin Abali

The following translations of the updated 2010 guidelines will be available soon.

Italian - Translated December 7, 2005MASCC Guidelines Italian    |   MASCC Guidelines Italian  (ppt)
Translated by Dr. Garassina

Korean Translation - Translated December, 2008MASCC Guidelines-Korean 
Thanks to Dr. Young Seon Hong for guideline translation 


MASCC Endorsed Guideline Partnerships

Guideline for the Prevention and Treatment of Anticipatory Nausea and Vomiting Due to Chemotherapy in Pediatric Cancer Patients
The Pediatric Oncology Group of Ontario (POGO) has published "Guideline for the Prevention and Treatment of Anticipatory Nausea and Vomiting due to Chemotherapy in Pediatric Cancer Patients” (April 2014). This evidence-based guideline contains recommendations for optimizing control of anticipatory nausea and vomiting  in children from 1 month to 18 years of age who are receiving chemotherapy. Recommendations for both pharmacological and nonpharmacological interventions are included.  >> Read the Guideline  *Disclaimer* The evidence used in formulating this guideline was rated as "low level" by the authors and much of it was derived from evidence in the adult population, rather than a pediatric population. While the conclusions have face validity, the strength of the recommendations is limited by a dearth of high-quality data. There remains a need for more studies in the pediatric population. 

Acute AINV Guideline for Pediatric Cancer Patients
The Pediatric Oncology Group of Ontario (POGO) has published “Guideline for the Prevention of Acute Nausea and Vomiting due to Antineoplastic Medication in Pediatric Cancer Patients” (April 2014). The purpose of this guideline is to provide healthcare providers with an approach to the prevention of acute antineoplastic-induced nausea and vomiting (AINV) in children. The scope is limited to the prevention of AINV in the acute phase (within 24 hours of antineoplastic administration).  >> Quick Review Summary


MASCC Antiemetic Guidelines © 2016 MASCC, Multinational Association for Supportive Care in Cancer™ •  All rights reserved worldwide.
For Questions or additional information, contact Executive Director, Aage Schultz,  aschultz@mascc.org